Family Medicine Doctors in Clarion, IA Accepting Medicare

7 Family Medicine doctors found. Showing 1 - 7

Anastasia Cherie Burke, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 215 13th Ave Sw, Clarion, IA 50525 Phone: 515-602-9833    Fax: 193-431-1613

Dr. Michael J Whitters, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 13th Ave Sw, Clarion, IA 50525 Phone: 515-532-2836    Fax: 515-532-2523

Dustin R Smith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1316 S Main St, Clarion, IA 50525 Phone: 515-532-2811

Dr. Jon S Ahrendsen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 13th Ave Sw, Clarion, IA 50525 Phone: 515-532-2836    Fax: 515-532-2523

Andrea Marie Mcloughlin, , M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1316 S Main St, Clarion, IA 50525 Phone: 515-532-2811    Fax: 515-532-9336

Nik M Nikoueiha, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1316 S Main St, Clarion, IA 50525 Phone: 515-532-2811    Fax: 515-532-9336

Amanda R Tew, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 13th Ave Sw, Clarion, IA 50525 Phone: 515-532-2836    Fax: 515-532-2523

News Archive

Researchers develop model to predict mortality risk for celiac disease patients

An international research team led by Mayo Clinic has developed a first-of-its-kind model to predict mortality in patients suffering from celiac disease (CD).

New study investigates hospital cardiac arrest in people with COVID-19 infection

Even when a sudden cardiac arrest happens inside a top hospital, where a code blue team is readily available, most people won't survive.

Cardio3 BioSciences announces first patient enrollment in NKG2D CAR T-Cell Phase I clinical trial

Cardio3 BioSciences (C3BS), a leader in engineered cell-therapy treatments with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced the enrollment of the first patient in a Phase I clinical trial evaluating the Company's lead CAR T-Cell therapy, NKG2D CAR T-Cell, in blood cancer patients with acute myeloid leukemia (AML) or multiple myeloma (MM).

Viewpoints: Researchers see potential to control HIV pandemic; The 'ceaseless attacks' on women's reproductive health

We are at a moment of extraordinary optimism in the response to the human immunodeficiency virus (HIV). A series of scientific breakthroughs ... have the potential to markedly expand the available preventive tools. There is evidence of the first cure of an HIV-infected person. And most important, the finding that early initiation of antiretroviral therapy can both improve individual patient outcomes and reduce the risk of HIV transmission to sexual partners by 96% has led many to assert what had so long seemed impossible: that control of the HIV pandemic may be achievable.

Osteopathic physicians, researchers to present clinical and research updates at OMED 15

Osteopathic physicians, researchers and aligned medical professionals will present clinical and research updates in 15 specialties at OMED 15 in Orlando October 17-21.

Read more Medical News

› Verified 8 days ago